This Final Amendment relates to the Issuer Tender Offer Statement on Schedule TO (the “Statement”) originally filed on January 2, 2020 by BlackRock Credit Allocation Income Trust, a diversified,closed-end management investment company organized as a Delaware statutory trust (the “Trust”), pursuant to Rule 13e-4 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), in connection with an offer by the Trust (the “Offer”) to repurchase up to 10% of its issued and outstanding common shares of beneficial interest, par value $0.001 per share (the “Shares”), in exchange for cash at a price equal to 98% of the net asset value per Share determined as of the close of the regular trading session of the New York Stock Exchange, the principal market in which the Shares are traded, on the day the Offer expires, upon the terms and subject to the conditions set forth in the Offer to Purchase, dated January 2, 2020 (the “Offer to Purchase”), and in the related Letter of Transmittal.
This is the Final Amendment to the Statement and is being filed to report the results of the Offer. Capitalized terms not otherwise defined herein shall have the meanings ascribed to them in the Offer to Purchase.
The following information is furnished to satisfy the requirements pursuant to Rule 13e-4(c)(4) of the Exchange Act.
| 1. | The Offer expired at 5:00 p.m. Eastern time, on February 3, 2020. |
| 2. | 41,241,878 Shares of the Trust were validly tendered and not withdrawn prior to the expiration of the Offer, and 10,386,555 of those Shares were accepted for repurchase by the Trust in accordance with the terms of the Offer. |
| 3. | The Shares were repurchased at a price of $14.945. |
Except as specifically provided herein, the information contained in the Statement, the Offer to Purchase and the Letter of Transmittal remains unchanged and this Amendment does not modify any of the information previously reported on the Statement, the Offer to Purchase or the Letter of Transmittal.
The information contained in the Offer to Purchase and the Letter of Transmittal, previously filed with the Schedule TO as Exhibits (a)(1)(i) and (a)(1)(ii), respectively, is incorporated by reference into this Amendment No. 2 in answer to Items 1 through 9 and Item 11 of the Schedule TO.
Item 10. | Financial Statements. |
Not applicable.
Item 12 of the Schedule TO is hereby amended and supplemented to add the following exhibit:
(a)(5)(iv) Press Release dated February 4, 2020.
Item 13. | Information Required by Schedule 13E-3. |
Not applicable.
- 2 -